Canton Barry — SEC Form 4 filings
SEC reporting owner CIK 1882756. 4 Form 4 filings on record with FilingPulse; latest filed 2026-07-30.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-04-29 to 2026-07-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 150,998 shares, $977,561 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 124,727 shares @ $6.43 ($802,494) in Ginkgo Bioworks Holdings, Inc., filed 2026-04-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc. (DNA) | 10% owner | 4 | — | 3 legs · 150,998 sh · $977,561 | 12 |
Form 4 filings — Canton Barry
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-30 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 35,736 (derivative) · Grant/award (A): 117,135 (derivative) · Grant/award (A): 39,038 (derivative) · Grant/award (A): 127,423 (derivative) | EDGAR |
| 2026-04-13 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Option exercise (M): 251,786 · Sale (S): 124,727 @ $6.43 · Option exercise (M): 251,786 (derivative) | EDGAR |
| 2026-04-10 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Option exercise (M): 27,738 · Option exercise (M): 27,738 · Sale (S): 13,155 @ $6.93 · Sale (S): 13,116 @ $6.40 · Option exercise (M): 27,738 (derivative) · Option exercise (M): 27,738 (derivative) | EDGAR |
| 2024-04-29 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 5,000,000 (derivative) @ $0 · Grant/award (A): 5,000,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1882756 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →